These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. Mavissakalian M, Michelson L, Dealy RS. Br J Psychiatry; 1983 Oct; 143():348-55. PubMed ID: 6626853 [Abstract] [Full Text] [Related]
27. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS. J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912 [Abstract] [Full Text] [Related]
32. Imipramine treatment of panic disorder with agoraphobia: the second time around. Mavissakalian MR, Perel JM, de Groot C. J Psychiatr Res; 1993 May; 27(1):61-8. PubMed ID: 8515390 [Abstract] [Full Text] [Related]
33. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Pohl R, Balon R, Yeragani VK, Gershon S. Psychopathology; 1989 May; 22 Suppl 1():60-7. PubMed ID: 2657839 [Abstract] [Full Text] [Related]
36. Autonomic changes after treatment of agoraphobia with panic attacks. Roth WT, Telch MJ, Taylor CB, Agras WS. Psychiatry Res; 1988 Apr; 24(1):95-107. PubMed ID: 3393620 [Abstract] [Full Text] [Related]
37. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Swinson RP, Pecknold JC, Kuch K. Prog Neuropsychopharmacol Biol Psychiatry; 1987 Apr; 11(2-3):105-13. PubMed ID: 3628823 [Abstract] [Full Text] [Related]
39. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome. Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H. Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806 [Abstract] [Full Text] [Related]